Have you read our lung cancer special issue yet?
There's SABR, palliative radiotherapy, genomics, screening, oligomets, an update on mesothelioma... and much more!
Something to please everyone! Read it here ➡️ https://t.co/nUcCYN2eQe
#LungCancer#LCSM
11/ Palliative RT has a role to play in metastatic NSCLC? @ClinOncologist@HattonMQF and colleagues review the current evidence and introduce the soon-to-open UK study TOURIST➡️https://t.co/ZxYiwaIhQb
People with lung cancer can access a new treatment options summary which brings together all of our guideline recommendations & technology appraisal guidance on advanced non-small-cell #lungcancer in a simple to use visual guide.
Find out more: https://t.co/TtxCqtnO96
#NICENews
1 DAYS TO GO! Submit your abstract for #BTOG21 at https://t.co/r84dKemXMV Deadline: TOMORROW - Monday 22nd March at 12noon. There will be NO extensions to this closing date. #LCSM#LungCancer@DrSanjayPopat@tnewsomdavis
You can still apply to represent the patient community on #NCRI_CTRad. The group is looking for a new consumer member, a cancer patient or carer with experience of #Radiotherapy.
https://t.co/NNuKpboe3Z
Good run back from Doncaster, so time to prepare for the lung cancer management webinar this evening. Strong program, looking forward to some interesting chat @RoySocMed
@BTOGORG@NCRI_partners A bit more updating on our national radiotherapy studies in meeting room 7 shortly with protocol amendments for SARON and ADSCaN.
@PattyDiezH @shepherde1711 @NcccOncology@SheffieldHosp@SouthTees A truly multidisciplinary presentation reflecting the approach needed to deliver this treatment. Really heartened by the interest shown.